License Grant Clause: Scope, Exclusivity & Drafting

TL;DR: A license grant clause is the operative provision that transfers specified rights in intellectual property from a licensor to a licensee while the licensor retains ownership. The clause defines five core variables: scope of rights granted, exclusivity, territory, duration, and field of use. Without a properly drafted grant, the licensee receives nothing of legal value, and a poorly bounded grant can effectively transfer ownership in economic terms while leaving the licensor with paper title.

‍

What Is a License Grant Clause?

A license is permission, not a transfer. The licensee gets the right to use specified intellectual property without taking ownership of it. The license grant clause is the operative sentence that creates that permission, typically beginning with verbs like "grants," "hereby grants," or "licenses" followed by a precise specification of what is granted, to whom, with what restrictions, and for how long.

The grant clause is distinct from the rest of a license agreement. Payment, audit rights, warranties, indemnification, and termination provisions all matter, but the grant clause is the core promise. If the grant fails (because the licensor lacks the underlying rights, the scope is unclear, or the field of use is not properly defined) the rest of the agreement collapses around it. Courts construing license agreements consistently start with the grant clause and work outward.

The five drafting variables of any grant clause are scope, exclusivity, territory, duration, and field of use. Scope identifies the IP rights granted (copy, distribute, make derivative works, publicly perform, manufacture, use, sell, sublicense). Exclusivity addresses whether the licensor can grant the same rights to others (sole, exclusive, non-exclusive). Territory limits where the licensee may exercise the rights (worldwide, US-only, named countries). Duration sets a fixed term, ties it to a triggering event, or makes the grant perpetual. Field of use limits the markets or applications in which the licensee can use the IP (e.g., "oncology only," "automotive only," "educational use only").

The IP type matters. A patent license grants rights under specific patent claims; the contract should list patent numbers and any continuations or divisionals. A copyright license grants the rights enumerated in 17 U.S.C. § 106, which the licensor must list expressly because the default is no license. A trademark license must include quality control provisions to avoid "naked licensing" that could invalidate the mark. A trade secret license is contractual and must include confidentiality and use-restriction language because there is no statutory framework for trade-secret transfer.

‍

Why It Matters

Scope ambiguity creates infringement exposure: A licensee that exceeds the scope of a license commits infringement, not breach of contract. The remedies differ sharply: copyright statutory damages can run up to $150,000 per willfully infringed work under 17 U.S.C. § 504(c), with attorneys' fees available, while breach of contract gives only actual damages.
Exclusivity drives valuation: An exclusive license is treated as an assignment for many purposes (including standing to sue infringers under 35 U.S.C. § 281 for patents and 17 U.S.C. § 501(b) for copyrights). A non-exclusive license carries no standing and far less economic value.
Field of use prevents value leakage: A medical-imaging algorithm licensed for radiology is worth far more than the same algorithm licensed for any imaging application. Field of use restrictions let a licensor monetize different applications through different licensees.
Naked trademark licensing voids the mark: Trademark licensors who fail to police quality risk having the mark deemed abandoned under Lanham Act principles. The grant must be paired with quality control rights and meaningful enforcement.
Sublicensing rights compound exposure: A grant that includes "the right to sublicense" without restriction can multiply licensees uncontrollably. Sublicense grants are typically more limited (e.g., to affiliates only, with prior written consent, or terminating automatically when the head license terminates).
Improper grants block transactions: Acquirers of patent and software companies routinely find that prior license grants were too broad to permit a clean sale. Cleanup costs (renegotiations, releases, indemnities) often run into millions.

‍

Key Elements of a Well-Drafted License Grant Clause

Identification of IP: Specific patent numbers, copyright registrations, trademark registrations, software product names with version numbers, or trade-secret descriptions in a confidential schedule. Avoid generic references like "all IP relating to the Product."
Specific rights granted: For copyrights, list which of the § 106 rights (reproduce, prepare derivatives, distribute, publicly perform, publicly display, digitally transmit). For patents, state "make, have made, use, sell, offer to sell, import." For trademarks, state the licensed marks, classes of goods or services, and quality standards.
Exclusivity designation: Choose carefully among non-exclusive, sole (licensor and one licensee), and exclusive (only the licensee, even excluding licensor). State whether exclusivity is subject to existing licenses or pre-grant obligations.
Territory: Worldwide, named countries, or geographic regions. For patents, the territory cannot exceed the geographic reach of the patents (a US patent gives no rights in Germany).
Duration: Fixed term (e.g., five years), tied to IP duration (e.g., "life of the patents"), or perpetual. State whether the grant survives termination of other agreements.
Field of use: Specific applications, industries, or markets. Use defined terms ("Field" defined in a schedule) to permit later amendment without disturbing the grant clause.
Sublicensing rights: Permitted, prohibited, or permitted only with consent or to affiliates. State whether sublicensee terms must be at least as protective as the head license.
Reservation of rights: Express reservation by licensor of all rights not granted. This forecloses arguments that ambiguity should be resolved in licensee's favor.

‍

Market Position & Benchmarks

Where Does Your Clause Fall?

Licensor-Favorable: Non-exclusive license, narrow field of use, short term, single jurisdiction, no sublicensing rights, broad reservation of rights, and termination on any breach. Licensor retains full ability to license to competitors and revoke for any non-compliance.
Market Standard: Non-exclusive (or sole) license, defined field of use, multi-year term tied to milestone or payment performance, regional or worldwide territory, sublicensing only to affiliates and with consent, and termination tied to material uncured breach. Most B2B software and IP licenses sit here.
Licensee-Favorable: Exclusive license, broad field of use, perpetual or long-term, worldwide, free sublicensing rights, with termination only for uncured material breach plus opportunity to cure. Common for spin-out university IP licenses and key R&D collaborations.

Market Data

The Association of University Technology Managers (AUTM) Licensing Activity Survey reports that universities executed approximately 8,500 license agreements in fiscal 2023, with the median grant being non-exclusive in a defined field of use.
Patent license royalty rates by industry (RoyaltyStat data, 2024): pharma 4-8 percent of net sales, medical devices 3-6 percent, software 5-15 percent, semiconductors 1-3 percent. Exclusivity typically increases the royalty by 50 to 200 percent over a comparable non-exclusive grant.
A 2024 Boston Consulting Group analysis of 200 enterprise software licenses found that 35 percent contained "all-rights" grants exceeding the customer's actual use case, leaving licensors unable to monetize adjacent applications without breach risk.
In US litigation, exclusive licensees have standing to sue for patent infringement under 35 U.S.C. § 281 and copyright infringement under 17 U.S.C. § 501(b); non-exclusive licensees do not. This is a primary driver of why sophisticated licensees push hard for exclusivity.
Median field-of-use restriction in biotech licenses (2024 Deloitte survey) limits licensees to a single therapeutic indication; broadening to multiple indications typically increases upfront fees by 2 to 3x.
Software licenses with broad sublicensing rights are valued at approximately 1.4x the equivalent license without sublicensing, per LES (Licensing Executives Society) 2024 valuation benchmarks.

Sample Language by Position

Licensor-Favorable: "Subject to the terms of this Agreement, Licensor hereby grants to Licensee a personal, non-transferable, non-sublicensable, non-exclusive, revocable license, limited to the United States, to use the Licensed Software solely for Licensee's internal business operations in the field of automotive parts manufacturing during the Term. Licensor reserves all rights not expressly granted, including without limitation the right to license the Licensed Software to any third party for any purpose."

Market Standard: "Licensor hereby grants to Licensee a worldwide, non-exclusive, non-transferable license, with the right to sublicense to its Affiliates with prior written notice to Licensor, under the Licensed Patents and Licensed Know-How to make, have made, use, sell, offer to sell, and import Licensed Products in the Field of Use during the Term. Licensor reserves all rights not expressly granted."

Licensee-Favorable: "Licensor hereby grants to Licensee a perpetual, irrevocable, worldwide, exclusive (even as to Licensor) license, with the unrestricted right to sublicense through multiple tiers, under the Licensed IP to make, have made, use, sell, offer to sell, import, copy, distribute, publicly perform, publicly display, modify, and prepare derivative works of the Licensed Products in any field of use. Such license shall be fully paid-up and royalty-free following payment of the Upfront Fee."

‍

Example Clause Language

Software-as-a-service license with end-user limitation:

SaaS License Grant: "Subject to Customer's compliance with this Agreement and payment of the Subscription Fees, Licensor grants Customer a non-exclusive, non-transferable, non-sublicensable, worldwide license, during the Subscription Term, to access and use the SaaS Service solely for Customer's internal business purposes and only for the number of Authorized Users set forth in the applicable Order Form. Customer shall not (a) provide access to the SaaS Service to any third party (other than Authorized Users), (b) use the SaaS Service to provide a service bureau or hosted service to any third party, or (c) reverse engineer, decompile, or disassemble the SaaS Service."

Patent license with field of use and sublicensing carve-outs:

Patent License with Field of Use: "Licensor hereby grants Licensee a worldwide, exclusive, royalty-bearing license, with the right to sublicense to Affiliates and to bona fide collaboration partners with prior written consent of Licensor (such consent not to be unreasonably withheld), under the Licensed Patents to make, have made, use, sell, offer for sale, and import Licensed Products in the Field. The Field is defined as: human therapeutic applications in the diagnosis, treatment, or prevention of solid tumor oncology indications. Outside the Field, Licensor retains all rights and may license the Licensed Patents to any third party."

Trademark license with quality control provisions:

Trademark License with Quality Control: "Licensor grants Licensee a non-exclusive, non-transferable, non-sublicensable license to use the Licensed Marks solely on or in connection with the Licensed Products in the Territory during the Term, in the form and on the goods identified in Schedule A. All use of the Licensed Marks shall comply with the Brand Guidelines provided by Licensor. Licensee shall submit samples of all Licensed Products bearing the Licensed Marks to Licensor for approval at least 30 days before commercial release. All goodwill arising from Licensee's use of the Licensed Marks shall inure to the benefit of Licensor."

‍

Common Contract Types

Software license agreements: The grant defines whether the license is per-user, per-device, per-CPU, or by some other metric, and whether it includes object code, source code, or both.
Patent license agreements: Heavily focused on which patents (and continuations) are licensed, the geographic scope (limited by patent jurisdictions), and any have-made rights for contract manufacturing.
Trademark license agreements: Always include quality control to avoid naked licensing and abandonment risk under the Lanham Act.
Copyright license agreements: Must enumerate which § 106 rights are granted; courts narrowly construe ambiguous grants in favor of the copyright holder.
Technology transfer agreements: Typically combine patent, trade secret, and know-how licenses with technical support and milestone-based payments.
Cross-license agreements: Each party grants the other a license, often used to resolve patent disputes or build interoperability.
Open-source compliance agreements: The license grant comes from the open-source license itself (MIT, Apache 2.0, GPL), but commercial agreements layered on top often include additional grants and warranties.
Franchise agreements: A specialized license including trademarks, trade dress, operating systems, and goodwill, governed by federal franchise rules and state franchise statutes.

‍

Negotiation Playbook

Key Drafting Notes

State the grant in one sentence: Long, multi-clause grants invite ambiguity. The five variables (scope, exclusivity, territory, duration, field) should fit in one carefully drafted sentence supplemented by a defined-terms schedule.
Define key terms with care: "Affiliate," "Field," "Licensed Patents," "Licensed Products," "Net Sales," and "Territory" should be defined precisely. Many disputes turn on whether a future product falls within a defined term.
Use "have made" rights deliberately: The right to "have made" lets the licensee use contract manufacturers. Without it, every CMO must take a separate sublicense, which creates audit and royalty complications.
Address improvements explicitly: Improvements made by either party often blur the original grant. Decide who owns improvements, who must disclose them, and whether they are automatically included in the license.
Coordinate with reps and warranties: A grant of "all rights" the licensor owns is meaningless if the IP rep is limited to "to licensor's knowledge." Match the breadth of the grant to the breadth of the warranty, or the licensor will under-deliver.
Anchor field of use to a defined term: A defined Field can be amended through a schedule update without reopening the grant clause. Hard-coding the field in the grant clause makes future expansion harder.

Common Pitfalls

Calling something "exclusive" without excluding licensor: A license that is "exclusive" but lets licensor still practice the IP is often called "sole" instead. Confusion over the difference is one of the most frequent IP litigation issues.
Granting "all rights" without limitation: Broad grants are easy to draft but destroy future monetization. Most experienced licensors instead start narrow and expand by amendment.
Mismatching the grant to the IP type: Patent rights expire when the patent expires; copyright rights last for the life of the author plus 70 years; trademark rights persist with use. A perpetual patent license is meaningless after expiration.
Failing to address sublicensee survival on termination: If the head license terminates, do existing sublicenses survive? Most contracts say no, but courts have inconsistently treated this absent express language.
Ignoring bankruptcy risk: Under 11 U.S.C. § 365(n), licensees of intellectual property have special rights if the licensor enters bankruptcy. Licenses that do not invoke § 365(n) protections may leave the licensee unprotected if the licensor rejects the contract.
Loose territory drafting: "North America" is ambiguous (does it include Mexico? Caribbean territories?). State specific countries or use a defined Territory that lists them.

‍

Jurisdiction Notes

U.S.: The grant clause's enforceability depends on the IP type. Patent licenses are governed by federal law and contract; an exclusive licensee has standing to sue for infringement under 35 U.S.C. § 281. Copyright licenses are governed by 17 U.S.C. § 204 (transfers must be in writing); exclusive licensees have standing under § 501(b). Trademark licenses must include quality control to avoid naked licensing under Eva's Bridal v. Halanick Enterprises (7th Cir. 2011). Trade secret licenses are governed by the Defend Trade Secrets Act (18 U.S.C. § 1836) and state UTSA versions.
U.K.: Patents Act 1977 and Copyright, Designs and Patents Act 1988 govern statutory IP rights. The Trade Marks Act 1994 § 28 allows licenses but requires registration of exclusive licenses to bind successors. UK courts are more willing than US courts to imply terms into license grants under the Belize Telecom test.
Other: EU Technology Transfer Block Exemption Regulation (TTBER, Regulation 316/2014) permits most license grants under 30 percent market share but restricts certain hardcore restraints (price-fixing, output limits, customer allocation, exclusive rights for non-severable improvements). China's Patent Law (2020 amendments) and Civil Code (effective 2021) recognize patent licenses but require recordation with the China National Intellectual Property Administration (CNIPA) for enforceability against bona fide third parties.

‍

Related Clauses

Sublicense Clause - the companion provision allowing licensee to grant rights to its own customers or affiliates.
Royalty Clause - sets the financial consideration for the license grant.
IP Clause - the umbrella provision addressing IP ownership and broader IP allocation in a contract.
Work for Hire - the alternative to a license; transfers ownership rather than granting use rights.
Audit Clause - lets licensor verify licensee's reported royalties and use within the licensed scope.
Confidentiality - protects trade secrets and know-how that often accompany the license grant.
Term Clause - works alongside the grant duration to address renewal, termination, and post-termination effects.
Indemnification - allocates third-party IP infringement risk between licensor and licensee.

‍

This glossary entry is provided for informational and educational purposes only. It does not constitute legal advice, and no attorney-client relationship is formed by reading this content. Consult qualified legal counsel for advice on specific contract matters.